7Baggers
 how sentiment analysis helps forecast galectin therapeutics inc.  newser.com Mon, 22 Sep 2025 18:36:31 GMT
 15 Best Biotech Penny Stocks to Invest in Right Now  Insider Monkey Sun, 21 Sep 2025 19:03:27 GMT
 published on: 2025-09-17 20:08:02  newser.com Thu, 18 Sep 2025 01:08:02 GMT
 published on: 2025-09-17 12:49:30  newser.com Wed, 17 Sep 2025 17:49:30 GMT
 Galectin therapeutics CFO sells shares for $56,053  Investing.com India Mon, 15 Sep 2025 17:38:14 GMT
 published on: 2025-09-14 19:23:29  newser.com Mon, 15 Sep 2025 00:23:29 GMT
 Insider Trading At Galectin Therapeutics Inc (NASDAQ: GALT): What Did We Note?  stocksregister.com Sun, 14 Sep 2025 07:00:00 GMT
 published on: 2025-09-13 23:45:29  newser.com Sun, 14 Sep 2025 04:45:29 GMT
 published on: 2025-09-13 16:45:38  newser.com Sat, 13 Sep 2025 21:45:38 GMT
 published on: 2025-09-08 14:20:19  Newser Mon, 08 Sep 2025 19:20:19 GMT
 Galectin Therapeutics Highlights Promising Belapectin Results  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 Galectin Therapeutics : Corporate Presentation, September 2025  MarketScreener Mon, 08 Sep 2025 07:00:00 GMT
 Nuveen LLC Acquires New Position in Galectin Therapeutics Inc. $GALT  Defense World Mon, 08 Sep 2025 07:00:00 GMT

Galectin Therapeutics Inc
(NASDAQ:GALT) 

GALT stock logo

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharid...

Founded: 2000
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends